155 related articles for article (PubMed ID: 2871058)
1. The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia.
Browne J; Silver H; Martin R; Hart R; Mergener M; Williams P
J Clin Psychopharmacol; 1986 Apr; 6(2):88-92. PubMed ID: 2871058
[TBL] [Abstract][Full Text] [Related]
2. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
3. Clonidine trial in tardive dyskinesia. Therapeutic response, MHPG, and plasma DBH.
Tripodianakis J; Markianos M
Pharmacopsychiatry; 1986 Sep; 19(5):365-7. PubMed ID: 3534900
[TBL] [Abstract][Full Text] [Related]
4. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
5. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H
Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663
[TBL] [Abstract][Full Text] [Related]
6. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Lohr JB; Caligiuri MP
J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
[TBL] [Abstract][Full Text] [Related]
7. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY
J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
[TBL] [Abstract][Full Text] [Related]
8. Gamma-Acetylenic GABA in tardive dyskinesia.
Casey DE; Gerlach J; Magelund G; Christensen TR
Adv Biochem Psychopharmacol; 1980; 24():577-80. PubMed ID: 6105803
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E in the treatment of tardive dyskinesia.
Akhtar S; Jajor TR; Kumar S
J Postgrad Med; 1993; 39(3):124-6. PubMed ID: 7914238
[TBL] [Abstract][Full Text] [Related]
10. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
[TBL] [Abstract][Full Text] [Related]
11. Buspirone in the treatment of tardive dyskinesia.
Moss LE; Neppe VM; Drevets WC
J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
Kocher R; Hobi V; Linder M; Studer K
Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric indications for clonidine: the neuropharmacologic and clinical basis.
Bond WS
J Clin Psychopharmacol; 1986 Apr; 6(2):81-7. PubMed ID: 3517082
[TBL] [Abstract][Full Text] [Related]
14. Preventing neuroleptic-induced tardive dyskinesia in adults and children.
Lam RW; Jeste SD; Jeste DV
Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652
[TBL] [Abstract][Full Text] [Related]
15. Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs.
Freedman R; Kirch D; Bell J; Adler LE; Pecevich M; Pachtman E; Denver P
Acta Psychiatr Scand; 1982 Jan; 65(1):35-45. PubMed ID: 6138923
[TBL] [Abstract][Full Text] [Related]
16. [Tiapride in the treatment of irreversible tardive dyskinesia--initial experiences].
Leblhuber F; Reisecker F; Bengesser G
Z Gerontol; 1987; 20(1):49-51. PubMed ID: 2883781
[TBL] [Abstract][Full Text] [Related]
17. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
Lerner V; Kaptsan A; Miodownik C; Kotler M
Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
[TBL] [Abstract][Full Text] [Related]
18. Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism.
Wirshing WC; Freidenberg DL; Cummings JL; Bartzokis G
J Clin Psychopharmacol; 1989 Dec; 9(6):407-11. PubMed ID: 2574192
[TBL] [Abstract][Full Text] [Related]
19. Tardive dyskinesia.
Soares-Weiser K; Fernandez HH
Semin Neurol; 2007 Apr; 27(2):159-69. PubMed ID: 17390261
[TBL] [Abstract][Full Text] [Related]
20. The natural history of tardive dyskinesia.
Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
